| Literature DB >> 22075380 |
Yaodong Zhao1, Chenghai Su, Hongyan Zhai, Yue Tian, Weihua Sheng, Jingcheng Miao, Jicheng Yang.
Abstract
Pancreatic cancer has a poor prognosis, even with surgery. ING4 is a member of the inhibitor of growth (ING) tumor suppressor family that has potent inhibitory effects on a variety of tumors; meanwhile, radiotherapy is a common adjunctive therapy for pancreatic cancer. Prior to this study, the effectiveness of a combination of ING4 gene-therapy and radiotherapy against pancreatic cancer had been unknown. In this study, we demonstrated that either ING4 or (125)I radiotherapy treatment could induce Panc-1 pancreatic cancer cell growth suppression and apoptosis in vitro. Furthermore, both treatments inhibited tumor growth and angiogenesis of Panc-1 pancreatic cancer subcutaneously xenografted in vivo. Moreover, the combination therapy had a synergistic effect.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22075380 DOI: 10.1016/j.canlet.2011.11.003
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679